Author:
Kuhns Lisa M.,Perloff Judy,Johnson Amy K.,Paul Josie Lynne,Pleasant Kevin,Evans Kaiji,Denson Damian J.,Gelaude Deborah J.,Bessler Patricia A.,Diskin Rose,Cervantes Marbella,Garofalo Robert,Hotton Anna L.
Abstract
Abstract
Background
Expanding pre-exposure prophylaxis (PrEP) among transgender women in the United States is an important strategy to meet national HIV prevention goals, however self-reported use of PrEP is low in this group.
Methods
This study reports the findings of a cross-sectional analysis of the relationship of barriers as well as facilitators to recent PrEP use among transgender women enrolled in an evaluation of the TransLife Care project (Chicago, Illinois), a structural intervention designed to meet basic needs. We computed multivariable prevalence ratios for barriers, facilitators and recent PrEP use, controlling for demographics.
Results
Findings suggest that psychosocial and structural barriers, including moderate/high alcohol use, stimulant use, and history of incarceration were all positively associated with recent PrEP use among urban transgender women. In addition, a psychosocial facilitator, gender affirmation, was positively associated with recent PrEP use, while, while collective self-esteem, a was negatively associated with it. Finally, common indications for PrEP have high sensitivity, but low specificity and predictive value for identifying those on PrEP.
Conclusion
We conclude that despite a large gap in PrEP use among those with indications, individuals experiencing psychosocial and structural barriers are more likely to use PrEP, and facilitators, such as psychological sense of affirmed gender may support its use.
Trial registration
N/A.
Funder
Centers for Disease Control and Prevention
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Virology,Molecular Medicine
Reference21 articles.
1. Centers for Disease Control and Prevention. HIV infection, risk, prevention, and testing behaviors among transgender women - national HIV behavioral surveillance, 7 U.S. cities, 2019–2020. http://www.cdc.gov/hiv/library/reports/hiv-surveillance.html; 2021 April.
2. Fauci AS, Redfield RR, Sigounas G, Weahkee MD, Giroir BP. Ending the HIV Epidemic: a plan for the United States. JAMA. 2019;321(9):844–5. https://doi.org/10.1001/jama.2019.1343]. [PMID 30730529].
3. Kuhns LM, Reisner SL, Mimiaga MJ, Gayles T, Shelendich M, Garofalo R. Correlates of PrEP indication in a Multi-Site Cohort of Young HIV-Uninfected Transgender Women. AIDS Behav. 2016;20(7):1470–7. https://doi.org/10.1007/s10461-015-1182-z. 1182-z] [PMID 26336946].
4. Parrish KC, Johnson HZ, Williams SL. PrEP navigation continuum among men who have sex with men, trans women, and people with alternative gender identities in three California counties. Eval Program Plann. 2022;90:101998doi. https://doi.org/10.1016/j.evalprogplan.2021.101998]. [PMID 34544606].
5. Malone J, Reisner SL, Cooney EE, Poteat T, Cannon CM, Schneider JS, et al. Perceived HIV Acquisition Risk and Low Uptake of PrEP among a cohort of Transgender Women with PrEP indication in the Eastern and Southern United States. J Acquir Immune Defic Syndr. 2021;88(1):10–8. https://doi.org/10.1097/qai.0000000000002726]. [PMID 34397742].
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献